Achilles Therapeutics plc (ACHL): Price and Financial Metrics

Achilles Therapeutics plc (ACHL): $0.86

0.02 (-2.78%)

POWR Rating

Component Grades








Add ACHL to Watchlist
Sign Up

Industry: Medical - Services




#48 of 74

in industry

ACHL Price/Volume Stats

Current price $0.86 52-week high $2.77
Prev. close $0.88 52-week low $0.75
Day low $0.86 Volume 5,455
Day high $0.92 Avg. volume 192,519
50-day MA $0.95 Dividend yield N/A
200-day MA $0.99 Market Cap 35.02M

ACHL Stock Price Chart Interactive Chart >

ACHL Latest News Stream

Event/Time News Detail
Loading, please wait...

ACHL Latest Social Stream

Loading social stream, please wait...

View Full ACHL Social Stream

Latest ACHL News From Around the Web

Below are the latest news stories about ACHILLES THERAPEUTICS PLC that investors may wish to consider to help them evaluate ACHL as an investment opportunity.

Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

- Achilles ADSs will continue to trade on the Nasdaq Global Select Market at this time, and the Company’s operations are not affected by the receipt of the Notice -LONDON, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal neoantigens to treat solid tumors, today disclosed that the Company received notice on September 20, 2023 from the Nasdaq Stock Market LLC (“N

Yahoo | September 22, 2023

Are Medical Stocks Lagging Achilles Therapeutics (ACHL) This Year?

Here is how Achilles Therapeutics PLC Sponsored ADR (ACHL) and HealthEquity (HQY) have performed compared to their sector so far this year.

Yahoo | September 22, 2023

Waters (WAT) Walk-Up Solutions Boost Bioprocess Development

Waters (WAT) launches new bioprocess walk-up solutions, automating sample prep and analysis from any bioreactor.

Yahoo | September 13, 2023

Is KalVista Pharmaceuticals (KALV) Stock Outpacing Its Medical Peers This Year?

Here is how KalVista Pharmaceuticals, Inc. (KALV) and Achilles Therapeutics PLC Sponsored ADR (ACHL) have performed compared to their sector so far this year.

Yahoo | September 6, 2023

Jazz (JAZZ) Beats on Q2 Earnings & Sales, Raises '23 View

Jazz (JAZZ) reports better-than-expected second-quarter results as earnings and sales beat expectations. The company raises its financial guidance for 2023.

Yahoo | August 10, 2023

Read More 'ACHL' Stories Here

ACHL Price Returns

1-mo -3.37%
3-mo -10.91%
6-mo -10.18%
1-year -68.09%
3-year N/A
5-year N/A
YTD -4.44%
2022 -82.04%
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!